title: Trichomoniasis: the "neglected" sexually transmitted disease.
abstract: Trichomonas vaginalis is the most prevalent nonviral sexually transmitted infection, affecting an estimated 3.7 million people in the United States. Although trichomoniasis is common, it has been considered a "neglected" sexually transmitted disease, due to limited knowledge of its sequelae and associated costs. This article reviews current epidemiology, pathophysiology, diagnostic methods, clinical management recommendations and special considerations, research on associated conditions and costs, prevention strategies, and controversies regarding trichomoniasis.
authors.affiliation: Division of STD Prevention, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road Northeast, MS E-02, Atlanta, GA 30333, USA. Electronic address: emeites@cdc.gov.
authors.forename: Elissa
authors.initials: E
authors.lastname: Meites
mesh_terms: D000981:Antiprotozoal Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D058069:Neglected Diseases; D015995:Prevalence; D012749:Sexually Transmitted Diseases; D014247:Trichomonas Vaginitis / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D014246:Trichomonas vaginalis; D014481:United States / Q000453:epidemiology
chemical_list: D000981:Antiprotozoal Agents
keywords: Nitroimidazoles; Nucleic acid amplification tests; Sexually transmitted disease; Trichomonas vaginalis; Urethritis; Vaginitis